Trials / Recruiting
RecruitingNCT07081243
Symplicity China Study
A Prospective, Single-group, Non-interventional, Non-blinded, Observational Study to Evaluate the Long-term Safety, Efficacy, and Durability of Symplicity Spyral Renal Denervation System in China
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Symplicity China study will evaluate the real-world long-term safety, efficacy, and durability of the Symplicity Spyral system in a population of approximately 500 renal denervation treated subjects with up to 36 months of follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Symplicity Spyral Renal Denervation System | Symplicity Renal Denervation |
Timeline
- Start date
- 2025-11-11
- Primary completion
- 2028-06-30
- Completion
- 2031-12-30
- First posted
- 2025-07-23
- Last updated
- 2025-11-17
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07081243. Inclusion in this directory is not an endorsement.